GlassScriptPhysician profile
Carl D Hassel
NPI 1114929502
$2,834.85
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,029 · 2020: $945 · 2021: $383 · 2022: $323 · 2023: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $154.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,017.35 | 2019-2020 | |
| Medtronic, INC. | $860.80 | 2021-2023 | Onyx Frontier |
| Medtronic Vascular, INC. | $230.57 | 2020 | |
| Amgen INC. | $113.21 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $111.29 | 2019-2020 | |
| Astellas Pharma US INC | $107.15 | 2019 | |
| Novartis Pharmaceuticals Corporation | $106.89 | 2019-2020 | |
| Pfizer INC. | $52.52 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.53 | 2019 | |
| Abbott Laboratories | $39.12 | 2019-2020 | |
| Cardiovascular Systems INC. | $30.35 | 2019-2020 | |
| Penumbra, INC. | $29.63 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.01 | 2019-2020 | |
| Ge Healthcare | $19.16 | 2019 | |
| Biotronik INC. | $18.12 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celonova Biosciences, INC. | $13.65 | 2019 | |
| Bardy Diagnostics, INC. | $12.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Hassel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.